Your browser doesn't support javascript.
loading
Past, Present and Future of Flow Cytometry in Breast Cancer - A Systematic Review.
Andreou, Maria; Vartholomatos, Evrysthenis; Harissis, Haralampos; Markopoulos, Georgios S; Alexiou, George A.
Afiliación
  • Andreou M; Haematology Laboratory-Unit of Molecular Biology, University Hospital of Ioannina, Greece.
  • Vartholomatos E; Haematology Laboratory-Unit of Molecular Biology, University Hospital of Ioannina, Greece.
  • Harissis H; Department of Surgery, University Hospital of Ioannina, Greece.
  • Markopoulos GS; Haematology Laboratory-Unit of Molecular Biology, University Hospital of Ioannina, Greece.
  • Alexiou GA; Laboratory of Biology, Department of Medicine, Faculty of Medicine, School of Health Sciences, Ioannina, Greece.
EJIFCC ; 30(4): 423-437, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31814815
ABSTRACT
Breast cancer is the most common malignancy in women worldwide. In this systematic review 28 studies were taken into account, in order to evaluate the role of DNA content and cell cycle phases, measured by flow cytometry in breast cancer. Presence of aneuploidy and S-phase fraction have been extensively studied as a prognostication tool. With the current dawn of the age of intraoperative flow cytometry the present systematic review provide an insight of the current role of flow cytometry in breast cancer and future horizons.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: EJIFCC Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: EJIFCC Año: 2019 Tipo del documento: Article